Core Insights - A research team from Liaoning He University and Shenyang He Eye Hospital published a study in the international journal "BMJ OPEN OPHTHALMOLOGY" comparing the vision-related quality of life and clinical efficacy of orthokeratology lenses (OK lenses), defocus glasses (DS glasses), and single vision glasses (SVS glasses) for myopic children and adolescents, providing important references for clinical choices in myopia optical interventions [1] Group 1 - The He Eye Hospital has actively responded to the national initiative "Light Project" by collaborating with Liaoning He University and He Eye Industry Group to establish a "365 Myopia Prevention and Control System" that utilizes big data, artificial intelligence, and genetic technologies [1] - This system emphasizes "precision" as a primary principle, customizing personalized plans based on genetic testing and vision examination data, addressing the shortcomings of traditional models [1] - The system covers the entire myopia development cycle, including prevention, early warning, control, and intervention, providing continuous management services [1] Group 2 - The integration of artificial intelligence and genetic diagnosis technologies allows for scientific risk prediction through myopia gene testing, enabling targeted measures to be taken [1] - The trend of early onset myopia is concerning, as high myopia, if not intervened in a timely manner, may lead to severe eye diseases such as retinal detachment [1] - Currently, SVS glasses are widely used due to their safety and affordability, while OK lenses and DS glasses are gradually gaining attention as new methods [1] Group 3 - The research team acknowledged limitations in their study and indicated the need for further research on the differences between various brands of lenses to provide more precise evidence for personalized correction plans [2]

Core Viewpoint - The research published in the international ophthalmology journal "BMJ OPEN OPHTHALMOLOGY" evaluates and compares the vision-related quality of life and clinical efficacy of different optical interventions for myopic children and adolescents in China, providing important references for clinical choices in myopia optical intervention [1] Group 1: Industry Context - The prevalence of myopia among children and adolescents in China is increasing, characterized by younger onset and more severe cases, which has raised significant social concerns [1] - The company actively responds to the national initiative "Light Project" by collaborating with various institutions to address myopia prevention and control [1] Group 2: Technological Integration - The establishment of the "365 Myopia Prevention and Control System" incorporates new technologies such as big data, artificial intelligence, and genetics to create personalized intervention plans based on genetic testing and vision examination data [1] - The system covers the entire myopia development cycle, including prevention, early warning, control, and intervention, providing continuous management services [1]

Core Insights - The Hubei Province Medical Technology Innovation Achievements Conference highlighted the establishment of the Hubei Brain-Computer Interface Industry Innovation Development Alliance, with Tongji Hospital as the chair unit [1] - Tongji Hospital showcased 46 innovative achievements, including 10 major breakthroughs in fields such as brain-computer interfaces, gene therapy, surgical robots, and smart medical platforms, demonstrating Hubei's strong capabilities in medical technology [1] - A significant achievement was the successful completion of the first implanted brain-computer interface surgery in Central China, marking a key advancement in functional reconstruction for patients [1] Group 1 - The Hubei Brain-Computer Interface Industry Innovation Development Alliance was officially established [1] - Tongji Hospital presented 46 innovative medical technology achievements, many of which are national or global firsts [1] - The conference was broadcasted live on CCTV, showcasing Hubei's medical technology strength to a global audience [1] Group 2 - The hospital's first implanted brain-computer interface surgery was completed in June, allowing a patient to independently drink water one month post-surgery [1] - The hospital is focusing on disruptive innovations in life sciences and health industry, as stated by Professor Tang Zhouping [1] - Various teams at Tongji Hospital are exploring different technical routes for brain-computer interfaces, including non-invasive and semi-invasive methods for treating chronic conditions and improving rehabilitation outcomes [2]